Congress temporarily suspends tariffs on imported formula to reduce cost
The Senate today passed and sent to the president for his signature the Formula Act (H.R. 8351), bipartisan legislation that would suspend tariffs on imported infant formula through 2022. The Food and Drug Administration has allowed formula imports to help address a U.S. formula shortage, but tariffs have increased the retail cost of these products. The Department of Health and Human Services offers a webpage to help health care providers and families locate formula.
Related News Articles
Headline
In this conversation, Kardie Tobb, D.O., a non-invasive preventative cardiologist at Cone Health, explains how multidisciplinary teams are breaking down…
Headline
The Health Resources and Services Administration Aug. 12 announced a modernized framework for addressing national newborn screening topics, which includes…
Headline
The Health Resources and Services Administration’s Rural Maternity and Obstetrics Management Strategies Program has released a report highlighting how three…
Headline
The AHA provided comments July 21 to the Senate Committee on Health, Education, Labor and Pensions on price transparency, nursing workforce and rural…
Headline
The Health Resources and Services Administration Maternal and Child Health Bureau has announced grant opportunities available supporting maternal and child…
Headline
In this conversation, Southwest Health’s Kevin Carr, M.D., family medicine physician, and Melissa Carr, M.D., OB/GYN, reflect on the joy of practicing medicine…